←
Mosio | for Research15,396 posts
Mosio | for Research avatar

Mosio | for Research

@mosio

Automated text messaging software for research, helping researchers improve engagement, adherence, and data collection.

◷ Joined October 2006▧ 11,178 Photos and videos
Mosio | for Research avatar
Mosio | for Research@mosio·Feb 13

Mosio Launches Mosio Tags: Streamlining Text Messaging Automations for REDCap Users New feature enables researchers to trigger text-based workflows directly from REDCap alerts, enhancing efficiency in clinical and translational research mosio.com/mosio-tags-pr/ #REDCap

Post attachment
Mosio | for Research avatar
Mosio | for Research@mosio·Aug 25

Study coordinators are already incredibly busy. They’re managing patient visits, data quality, IRB requirements, and endless follow-ups. The last thing they need is extra tech headaches. This is why automated text messaging is such a game changer. Simple reminders, adherence nudges, and data collection surveys go straight to patients’ phones. High open rates, no app downloads, minimal training required.Give busy coordinators tools that actually save them time instead of adding work. Automated text messaging for the win. What’s one thing that’s making your coordinators’ lives easier right now? #studycoordinator #principalinvestigator #nih

Mosio | for Research avatar
Mosio | for Research@mosio·Aug 13

Text messaging + REDCap is one of the smartest combos in clinical research right now. Instead of hoping participants remember to click a REDCap survey link, you can trigger automatic HIPAA-compliant SMS reminders and surveys that actually improve adherence and data collection. ✅ Higher survey completion rates. ✅ Better retention. ✅ Fewer missing data points. ✅ Works on any phone. Study teams get cleaner data without chasing patients. Participants get simple timely nudges. The future of trials isn’t forcing another app on people. It’s meeting them where they already are, in text messaging. Who else is combining REDCap with SMS automation? #REDCap #ClinicalResearch

Mosio | for Research avatar
Mosio | for Research@mosio·Aug 5

REDCap data entry for clinical trials needs to be fast, accurate, and intuitive. Research teams cannot afford sluggish workflows that leave them without a full picture of participant progress. Strong data management is critical to any successful trial, which is why REDCap has become one of the most trusted platforms in the field. While its core data capture features are proven, the real results come from how teams set it up and integrate it into their daily operations. REDCap delivers the most value when teams thoughtfully configure instruments, thoroughly test forms before launch, and design supporting communication processes around them. When paired with Mosio’s automated SMS tools, REDCap keeps participants actively engaged and ensures data arrives on time. Coordinators spend far less time chasing missing entries and more time advancing the study. Get an instant quote today at Mosio's website (link in bio). #DataCapture #NIHResearch #REDCap

3:50
Mosio | for Research avatar
Mosio | for Research@mosio·Aug 4

Mobile apps are quietly failing clinical research. Patients forget to download them, never open them, or get frustrated and drop out. Study teams waste hours troubleshooting login issues, compatibility problems, and tech support tickets. Study coordinators are researchers, not Genius Bar workers. They shouldn’t be spending their time acting as unpaid mobile tech support. This is exactly why SMS text messaging still wins. ✅ 98% open rates ✅No downloads, no logins, no updates ✅Reaches diverse and older populations ✅Simple, reliable, HIPAA-compliant tools exist today The best research tech is often the simplest. Let’s stop forcing complicated apps on participants and coordinators and go back to what actually works: text messaging. #ClinicalResearch #DigitalHealth #SMS

Mosio | for Research avatar
Mosio | for Research@mosio·Jul 30

Busy study coordinators deserve better tools. Between recruitment, retention, and clean data collection, their plates are full. They shouldn’t be troubleshooting apps or chasing study subjects for missing entries. Automated text messaging solves this. Timely reminders, simple survey links, and real-time adherence support, all delivered directly via SMS. Higher response rates, better data quality, and less burden on the team. The best research teams are the ones that give coordinators powerful but simple tools. Automated text messaging wins again. #clinicaltrials #nihresearch #SMS

Mosio | for Research avatar
Mosio | for Research@mosio·Jul 29

Love this myth-buster: You don’t need fancy technology to do good research. Simple tools like SMS, mobile surveys, and community networks often deliver higher quality data, especially in emerging markets. Sometimes the most effective solutions are the simplest ones. Texting works! Overcomplicating research methods can actually hurt participation and authenticity. Big reminder that human-centered design > shiny tools. Who else is keeping research accessible? Thoughts? #clinicaltrials #textmessaging

Myth 4: No tech, no research Myth: Research can’t happen without advanced technology. Reality: Simple tools like mobile surveys, SMS, and community networks often generate high-quality, reliable data. #DesignResearch #HumanCentredDesign #GlobalSouth #AfricanMarkets

Post attachment
Mosio | for Research avatar
Mosio | for Research@mosio·Jul 22

Clinical trial data collection software is empowering research teams to protect data integrity while easing the heavy workload that often leads to coordinator burnout. Across academic studies and large-scale, multi-site trials, one priority stands out: systems that eliminate unnecessary friction and let data move smoothly from participant to database. Coordinators frequently describe the same daily struggles. They are jumping between disconnected platforms, hunting down incomplete entries, and handling manual communications. Without better tools, these repetitive tasks quickly turn into major sources of stress that build up throughout the study lifecycle. Surprisingly, many trials still operate with fragmented, legacy approaches: paper case report forms, scattered email surveys, and standalone tools cobbled together. The consequences include delayed data, exhausted staff, and elevated compliance risks that ripple through the entire project. Modern clinical trial data collection software solves these challenges directly. By reducing manual work, it boosts data accuracy and transforms chaotic, reactive workflows into a clean, reliable system. REDCap remains a trusted foundation for academic and institutional research. It provides a secure, flexible platform for designing and managing data collection instruments. Teams are increasingly leveraging its advanced features such as conditional logic, automated reminders, and scheduled follow-ups to create a true command center for study timelines and participant outreach. With everything from survey status to pending tasks visible in one dashboard, coordinators can finally shift from firefighting to focused oversight. Yet technology alone is not enough. Consistent participant communication is critical for high completion rates and strong data quality. That is where Mosio makes a powerful impact. By delivering timely SMS reminders and direct survey links, teams see measurable improvements in response rates, reduced follow-up work, and higher overall engagement. Participants respond better when they receive clear, well-timed messages that keep them informed about next steps. Features like scheduled reminders, embedded survey links, and two-way texting for questions or check-ins create a supportive experience that benefits everyone. Instead of coordinators manually chasing responses, Mosio and REDCap work together seamlessly in the background. Communications happen automatically while clean data flows in on schedule. This combination has proven especially effective in vaccine trials, long-term follow-up studies, and mental health research. These are areas where participant adherence can be particularly difficult. High-performing teams succeed by mapping visit schedules and data plans early, automating communications wherever possible, and thoroughly testing integrations before enrollment begins. The focus is not on adding more tools, but on making the right ones work together intelligently. For new trials, the setup is simple and effective: Use REDCap as the secure backbone for structured data capture. Layer Mosio on top for proactive participant reminders and real-time check-ins. Align automated messages with the protocol’s visit calendar. And build in automation from day one to eliminate repetitive manual tasks. These strategies deliver real results. They save time, lower error rates, and make it far easier to manage multiple studies simultaneously. With rising standards for data quality and protocol compliance, clinical trial data collection software is gaining traction because it directly tackles the biggest obstacles: participant drop-off, communication gaps, and time-draining manual processes. When the right tools are properly connected, data arrives consistently, staff reclaim valuable time, participants remain engaged, and studies progress with fewer interruptions and less stress. #REDCap #ElectronicDataCapture #Research

4:01
Mosio | for Research avatar
Mosio | for Research@mosio·Jul 21

Not all texts are created equal. SMS, MMS, and RCS each have their own strengths (and gotchas) when it comes to delivery, branding, and getting replies. The problem with using RCS in clinical research remains accessibility and costs. #mosio #sms #textinginresearch

SMS, MMS, & RCS all send a text. That's where the similarity ends. Pick the wrong one & the message still goes out. It reaches fewer phones, drops your branding, or misses the tap that would have earned a reply. We broke down all three & when to use each. buff.ly/kXRf6qa

Post attachment
Mosio | for Research avatar
Mosio | for Research@mosio·Jul 16

📱 Biggest research subject adherence hack in 2026? Let participants use text messaging on their own phones. No more chasing devices or managing apps on patient phones. Personal devices = higher response rates, easier adherence reminders, and real-time data. It just works better. What’s your biggest friction point with participant comms right now? #ClinicalResearch #PatientRetention #Mosio

Mosio | for Research avatar
Mosio | for Research@mosio·Jul 14

eConsent Software for Clinical Trials eConsent solutions can be the difference between strong participant engagement and early drop-off in clinical trials. Research teams consistently share the same frustration: the consent process drags on far too long, leaving many participants feeling confused or overwhelmed right from the start. When that happens, data quality and enrollment momentum take an immediate hit. Despite increasingly sophisticated trial designs, too many studies still depend on outdated paper forms or static PDFs. The result? Slower recruitment, heavier administrative burdens, and a higher risk that participants never fully grasp what they’re signing up for. Consent should never stand in the way of scientific progress. Modern eConsent software streamlines the entire process, making enrollment quicker, more transparent, and far more effective for both research staff and participants. Mosio goes even further by integrating robust eConsent capabilities with reliable text messaging tools that maintain clear communication and engagement from enrollment through study completion. The outcome is smoother studies, reduced delays, and a noticeably less stressful experience for everyone involved. #clinicaltrials #eConsent

3:18
Mosio | for Research avatar
Mosio | for Research@mosio·Jul 13

A must-read 2026 study on SMS trends that actually boosted real engagement for nonprofits, unions & advocacy groups. In a world obsessed with flashy apps, simple text messaging is still crushing it for reach and response rates. Low-cost, high-impact tech that doesn’t require your audience to download anything. This is the kind of practical research every org should be studying. What’s your best SMS win (or lesson) this year? 👇 #TextMessaging #ClinicalResearch

A must-read 2026 study on SMS trends and tactics that boosted engagement for nonprofits, unions, and advocacy campaigns! hubs.ly/Q04mZ6gs0 ✅

Post attachment
Mosio | for Research avatar
Mosio | for Research@mosio·Jun 10

CHIP-BCIS3 shows elective unloading didn’t improve outcomes in complex PCI. These high-risk patients need strong engagement tech more than ever. Mosio’s text messaging + automated reminders help drive adherence and retention. turning trial data into better real-world care. #InterventionalCardiology

NEJM@NEJMMar 29

Presented at #ACC26: Among patients undergoing complex PCI, elective unloading with a microaxial flow pump did not reduce the risk of major adverse clinical outcomes as compared with standard care. Full CHIP-BCIS3 trial results: nejm.org/doi/full/10.1056/NE… Editorial: Price of Protection — Microaxial Flow Pump in High-Risk PCI nejm.org/doi/full/10.1056/NE… @ACCinTouch

Post attachment
Mosio | for Research avatar
Mosio | for Research@mosio·May 21

SMART-DECISION trial results are practice-changing for post-MI care. In trials like this, patient adherence and retention are everything. Mosio’s automated SMS reminders and REDCap-integrated workflows help keep participants engaged long-term: exactly what’s needed when de-prescribing or monitoring real-world outcomes. #Cardiology #ClinicalTrials

NEJM@NEJMApr 2

New in the April 2, 2026, issue of NEJM: Enfortumab Vedotin and Pembrolizumab in Bladder Cancer (phase 3 KEYNOTE-905/EV-303 trial) nejm.org/doi/full/10.1056/NE… Left Atrial Appendage Closure in Atrial Fibrillation (CLOSURE-AF trial) nejm.org/doi/full/10.1056/NE… Editing the HBG1 and HBG2 Promoters for Sickle Cell Disease (RUBY study) nejm.org/doi/full/10.1056/NE… Editing HBG1 and HBG2 Promoters for β-Thalassemia (EdiThal study) nejm.org/doi/full/10.1056/NE… Discontinuation of Beta-Blocker Therapy after MI (SMART-DECISION trial) nejm.org/doi/full/10.1056/NE… Subscribe to NEJM for the latest medical research: store.nejm.org/nejm/subscrib…

Post attachment
Mosio | for Research avatar
Mosio | for Research@mosio·May 19

Research teams keep telling us the same thing: "We tried to set up texting for our study. Then we hit 10DLC registration and it took weeks, sometimes months." 60-70% of healthcare registrations get rejected on the first try. Vague feedback. $15 per resubmission. Days of waiting. Mosio handles all of this for you. Every client. Every registration. Prevent rejections, no hassle on your end. Link in bio if you're stuck. #ClinicalResearch #10DLC #SMS

Post attachment